Caris Life Sciences, Inc. (CAI) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, everyone, and welcome to the CARES Life Sciences Q4 2025 Earnings Call. My name is Dana, and I will be your coordinator today. At this time, all participants are on the listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star-1-1 on your telephone. You will then hear an automated message advising that your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker, Russ Denton. Please go ahead. Thank you. Earlier today, Karis Life Sciences released financial results for the quarter and year ended December 31st, 2025. Joining the call from Karis today are David Dean-Holbert, our founder, chairman, and CEO, David Spetzler, our president, Brian Burley, our vice chairman and EBP, Bobby Hill, our chief commercial officer, and Luke Power, our CFO. Before we begin, I'd like to remind you that during this call, management will make forward-looking statements within the meeting of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated. These risks are discussed in our SEC filings, including our quarterly reports on Form 10-Q, and our annual report on Form 10-K to be filed with the SEC. Assessed as required by law, CARES disclaims any intention or obligation to update or revise financial projections and forward-looking statements, whether because of new information, future events, or otherwise. The information discussed in this conference call is accurate only as of the live broadcast. This call will also in...